Phage Therapy Industry Research Report 2023
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Highlights
The global Phage Therapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy.
The Phage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Phage Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Phage Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Phage Therapy segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Phage Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Phage Therapy market.
Phage Therapy Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Phage Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Phage Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Highlights
The global Phage Therapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy.
The Phage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- NPO Microgen
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences,Inc
- Pharmex Group,LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
Global markets are presented by Phage Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Phage Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Phage Therapy segment by Type
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Phage Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Phage Therapy market.
Phage Therapy Segment by Application
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Phage Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Phage Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Phage Therapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
2.3 Phage Therapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Animal Health
2.3.3 Aquaculture
2.3.4 Agriculture
2.3.5 Food Industry
2.3.6 Human Health
2.3.7 Others
2.4 Assumptions and Limitations
3 PHAGE THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Phage Therapy Historic Market Size by Type (2018-2023)
3.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028)
4 PHAGE THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Phage Therapy Historic Market Size by Application (2018-2023)
4.2 Global Phage Therapy Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Phage Therapy Market Perspective (2018-2029)
5.2 Global Phage Therapy Growth Trends by Region
5.2.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Phage Therapy Historic Market Size by Region (2018-2023)
5.2.3 Phage Therapy Forecasted Market Size by Region (2024-2029)
5.3 Phage Therapy Market Dynamics
5.3.1 Phage Therapy Industry Trends
5.3.2 Phage Therapy Market Drivers
5.3.3 Phage Therapy Market Challenges
5.3.4 Phage Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Phage Therapy Players by Revenue
6.1.1 Global Top Phage Therapy Players by Revenue (2018-2023)
6.1.2 Global Phage Therapy Revenue Market Share by Players (2018-2023)
6.2 Global Phage Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Phage Therapy Head office and Area Served
6.4 Global Phage Therapy Players, Product Type & Application
6.5 Global Phage Therapy Players, Date of Enter into This Industry
6.6 Global Phage Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Phage Therapy Market Size (2018-2029)
7.2 North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Phage Therapy Market Size by Country (2018-2023)
7.4 North America Phage Therapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Phage Therapy Market Size (2018-2029)
8.2 Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Phage Therapy Market Size by Country (2018-2023)
8.4 Europe Phage Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Phage Therapy Market Size (2018-2029)
9.2 Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Phage Therapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Phage Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Phage Therapy Market Size (2018-2029)
10.2 Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Phage Therapy Market Size by Country (2018-2023)
10.4 Latin America Phage Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Phage Therapy Market Size (2018-2029)
11.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Phage Therapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Phage Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 NPO Microgen
11.1.1 NPO Microgen Company Detail
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Phage Therapy Introduction
11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022)
11.1.5 NPO Microgen Recent Development
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Detail
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022)
11.2.5 Proteon Pharmaceuticals Recent Development
11.3 Phagelux
11.3.1 Phagelux Company Detail
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Phage Therapy Introduction
11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022)
11.3.5 Phagelux Recent Development
11.4 Intralytix
11.4.1 Intralytix Company Detail
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Phage Therapy Introduction
11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022)
11.4.5 Intralytix Recent Development
11.5 Micreos
11.5.1 Micreos Company Detail
11.5.2 Micreos Business Overview
11.5.3 Micreos Phage Therapy Introduction
11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022)
11.5.5 Micreos Recent Development
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Detail
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Phage Therapy Introduction
11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022)
11.6.5 Eliava BioPreparations Recent Development
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Detail
11.7.2 Locus Biosciences,Inc Business Overview
11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022)
11.7.5 Locus Biosciences,Inc Recent Development
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Detail
11.8.2 Pharmex Group,LLC Business Overview
11.8.3 Pharmex Group,LLC Phage Therapy Introduction
11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022)
11.8.5 Pharmex Group,LLC Recent Development
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Detail
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Phage Therapy Introduction
11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022)
11.9.5 Pherecydes Pharma Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Detail
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Detail
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022)
11.11.5 Qingdao Phagepharm Bio-tech Recent Development
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Detail
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Phage Therapy Introduction
11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022)
11.12.5 Fixed-Phage Limited Recent Development
11.13 Zeptometrix
11.13.1 Zeptometrix Company Detail
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Phage Therapy Introduction
11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022)
11.13.5 Zeptometrix Recent Development
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Detail
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Phage Therapy Introduction
11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022)
11.14.5 Phage International, Inc. Recent Development
11.15 MicroMir
11.15.1 MicroMir Company Detail
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Phage Therapy Introduction
11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022)
11.15.5 MicroMir Recent Development
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Detail
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022)
11.16.5 iNtODEWORLD, Inc. Recent Development
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Detail
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Phage Therapy Introduction
11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022)
11.17.5 NEXTBIOTICS Recent Development
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Detail
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022)
11.18.5 Armata Pharmaceuticals, Inc. Recent Development
11.19 Innophage
11.19.1 Innophage Company Detail
11.19.2 Innophage Business Overview
11.19.3 Innophage Phage Therapy Introduction
11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022)
11.19.5 Innophage Recent Development
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Detail
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022)
11.20.5 Adaptive Phage Therapeutics Recent Development
11.21 TechnoPhage
11.21.1 TechnoPhage Company Detail
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Phage Therapy Introduction
11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022)
11.21.5 TechnoPhage Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Phage Therapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
2.3 Phage Therapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Animal Health
2.3.3 Aquaculture
2.3.4 Agriculture
2.3.5 Food Industry
2.3.6 Human Health
2.3.7 Others
2.4 Assumptions and Limitations
3 PHAGE THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Phage Therapy Historic Market Size by Type (2018-2023)
3.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028)
4 PHAGE THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Phage Therapy Historic Market Size by Application (2018-2023)
4.2 Global Phage Therapy Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Phage Therapy Market Perspective (2018-2029)
5.2 Global Phage Therapy Growth Trends by Region
5.2.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Phage Therapy Historic Market Size by Region (2018-2023)
5.2.3 Phage Therapy Forecasted Market Size by Region (2024-2029)
5.3 Phage Therapy Market Dynamics
5.3.1 Phage Therapy Industry Trends
5.3.2 Phage Therapy Market Drivers
5.3.3 Phage Therapy Market Challenges
5.3.4 Phage Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Phage Therapy Players by Revenue
6.1.1 Global Top Phage Therapy Players by Revenue (2018-2023)
6.1.2 Global Phage Therapy Revenue Market Share by Players (2018-2023)
6.2 Global Phage Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Phage Therapy Head office and Area Served
6.4 Global Phage Therapy Players, Product Type & Application
6.5 Global Phage Therapy Players, Date of Enter into This Industry
6.6 Global Phage Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Phage Therapy Market Size (2018-2029)
7.2 North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Phage Therapy Market Size by Country (2018-2023)
7.4 North America Phage Therapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Phage Therapy Market Size (2018-2029)
8.2 Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Phage Therapy Market Size by Country (2018-2023)
8.4 Europe Phage Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Phage Therapy Market Size (2018-2029)
9.2 Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Phage Therapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Phage Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Phage Therapy Market Size (2018-2029)
10.2 Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Phage Therapy Market Size by Country (2018-2023)
10.4 Latin America Phage Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Phage Therapy Market Size (2018-2029)
11.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Phage Therapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Phage Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 NPO Microgen
11.1.1 NPO Microgen Company Detail
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Phage Therapy Introduction
11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022)
11.1.5 NPO Microgen Recent Development
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Detail
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022)
11.2.5 Proteon Pharmaceuticals Recent Development
11.3 Phagelux
11.3.1 Phagelux Company Detail
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Phage Therapy Introduction
11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022)
11.3.5 Phagelux Recent Development
11.4 Intralytix
11.4.1 Intralytix Company Detail
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Phage Therapy Introduction
11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022)
11.4.5 Intralytix Recent Development
11.5 Micreos
11.5.1 Micreos Company Detail
11.5.2 Micreos Business Overview
11.5.3 Micreos Phage Therapy Introduction
11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022)
11.5.5 Micreos Recent Development
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Detail
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Phage Therapy Introduction
11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022)
11.6.5 Eliava BioPreparations Recent Development
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Detail
11.7.2 Locus Biosciences,Inc Business Overview
11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022)
11.7.5 Locus Biosciences,Inc Recent Development
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Detail
11.8.2 Pharmex Group,LLC Business Overview
11.8.3 Pharmex Group,LLC Phage Therapy Introduction
11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022)
11.8.5 Pharmex Group,LLC Recent Development
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Detail
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Phage Therapy Introduction
11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022)
11.9.5 Pherecydes Pharma Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Detail
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Detail
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022)
11.11.5 Qingdao Phagepharm Bio-tech Recent Development
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Detail
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Phage Therapy Introduction
11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022)
11.12.5 Fixed-Phage Limited Recent Development
11.13 Zeptometrix
11.13.1 Zeptometrix Company Detail
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Phage Therapy Introduction
11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022)
11.13.5 Zeptometrix Recent Development
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Detail
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Phage Therapy Introduction
11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022)
11.14.5 Phage International, Inc. Recent Development
11.15 MicroMir
11.15.1 MicroMir Company Detail
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Phage Therapy Introduction
11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022)
11.15.5 MicroMir Recent Development
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Detail
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022)
11.16.5 iNtODEWORLD, Inc. Recent Development
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Detail
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Phage Therapy Introduction
11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022)
11.17.5 NEXTBIOTICS Recent Development
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Detail
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022)
11.18.5 Armata Pharmaceuticals, Inc. Recent Development
11.19 Innophage
11.19.1 Innophage Company Detail
11.19.2 Innophage Business Overview
11.19.3 Innophage Phage Therapy Introduction
11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022)
11.19.5 Innophage Recent Development
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Detail
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022)
11.20.5 Adaptive Phage Therapeutics Recent Development
11.21 TechnoPhage
11.21.1 TechnoPhage Company Detail
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Phage Therapy Introduction
11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022)
11.21.5 TechnoPhage Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Phage Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Phage Therapy Revenue Market Share by Type (2018-2023)
Table 7. Global Phage Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Phage Therapy Revenue Market Share by Type (2024-2029)
Table 9. Global Phage Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Phage Therapy Revenue Market Share by Application (2018-2023)
Table 11. Global Phage Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Phage Therapy Revenue Market Share by Application (2024-2029)
Table 13. Global Phage Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Phage Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Phage Therapy Market Share by Region (2018-2023)
Table 16. Global Phage Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Phage Therapy Market Share by Region (2024-2029)
Table 18. Phage Therapy Market Trends
Table 19. Phage Therapy Market Drivers
Table 20. Phage Therapy Market Challenges
Table 21. Phage Therapy Market Restraints
Table 22. Global Top Phage Therapy Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Phage Therapy Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Phage Therapy Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Phage Therapy, Headquarters and Area Served
Table 26. Global Phage Therapy Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Phage Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. NPO Microgen Company Detail
Table 46. NPO Microgen Business Overview
Table 47. NPO Microgen Phage Therapy Product
Table 48. NPO Microgen Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 49. NPO Microgen Recent Development
Table 50. Proteon Pharmaceuticals Company Detail
Table 51. Proteon Pharmaceuticals Business Overview
Table 52. Proteon Pharmaceuticals Phage Therapy Product
Table 53. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 54. Proteon Pharmaceuticals Recent Development
Table 55. Phagelux Company Detail
Table 56. Phagelux Business Overview
Table 57. Phagelux Phage Therapy Product
Table 58. Phagelux Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 59. Phagelux Recent Development
Table 60. Intralytix Company Detail
Table 61. Intralytix Business Overview
Table 62. Intralytix Phage Therapy Product
Table 63. Intralytix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 64. Intralytix Recent Development
Table 65. Micreos Company Detail
Table 66. Micreos Business Overview
Table 67. Micreos Phage Therapy Product
Table 68. Micreos Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 69. Micreos Recent Development
Table 70. Eliava BioPreparations Company Detail
Table 71. Eliava BioPreparations Business Overview
Table 72. Eliava BioPreparations Phage Therapy Product
Table 73. Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 74. Eliava BioPreparations Recent Development
Table 75. Locus Biosciences,Inc Company Detail
Table 76. Locus Biosciences,Inc Business Overview
Table 77. Locus Biosciences,Inc Phage Therapy Product
Table 78. Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 79. Locus Biosciences,Inc Recent Development
Table 80. Pharmex Group,LLC Company Detail
Table 81. Pharmex Group,LLC Business Overview
Table 82. Pharmex Group,LLC Phage Therapy Product
Table 83. Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 84. Pharmex Group,LLC Recent Development
Table 85. Pherecydes Pharma Company Detail
Table 86. Pherecydes Pharma Business Overview
Table 87. Pherecydes Pharma Phage Therapy Product
Table 88. Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 89. Pherecydes Pharma Recent Development
Table 90. APS Biocontrol Ltd. (APS) Company Detail
Table 91. APS Biocontrol Ltd. (APS) Business Overview
Table 92. APS Biocontrol Ltd. (APS) Phage Therapy Product
Table 93. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 94. APS Biocontrol Ltd. (APS) Recent Development
Table 95. Qingdao Phagepharm Bio-tech Company Detail
Table 96. Qingdao Phagepharm Bio-tech Business Overview
Table 97. Qingdao Phagepharm Bio-tech Phage TherapyProduct
Table 98. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 99. Qingdao Phagepharm Bio-tech Recent Development
Table 100. Fixed-Phage Limited Company Detail
Table 101. Fixed-Phage Limited Business Overview
Table 102. Fixed-Phage Limited Phage TherapyProduct
Table 103. Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 104. Fixed-Phage Limited Recent Development
Table 105. Zeptometrix Company Detail
Table 106. Zeptometrix Business Overview
Table 107. Zeptometrix Phage TherapyProduct
Table 108. Zeptometrix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 109. Zeptometrix Recent Development
Table 110. Phage International, Inc. Company Detail
Table 111. Phage International, Inc. Business Overview
Table 112. Phage International, Inc. Phage TherapyProduct
Table 113. Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 114. Phage International, Inc. Recent Development
Table 115. MicroMir Company Detail
Table 116. MicroMir Business Overview
Table 117. MicroMir Phage TherapyProduct
Table 118. MicroMir Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 119. MicroMir Recent Development
Table 120. iNtODEWORLD, Inc. Company Detail
Table 121. iNtODEWORLD, Inc. Business Overview
Table 122. iNtODEWORLD, Inc. Phage TherapyProduct
Table 123. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 124. iNtODEWORLD, Inc. Recent Development
Table 125. NEXTBIOTICS Company Detail
Table 126. NEXTBIOTICS Business Overview
Table 127. NEXTBIOTICS Phage TherapyProduct
Table 128. NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 129. NEXTBIOTICS Recent Development
Table 130. Armata Pharmaceuticals, Inc. Company Detail
Table 131. Armata Pharmaceuticals, Inc. Business Overview
Table 132. Armata Pharmaceuticals, Inc. Phage TherapyProduct
Table 133. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 134. Armata Pharmaceuticals, Inc. Recent Development
Table 135. Innophage Company Detail
Table 136. Innophage Business Overview
Table 137. Innophage Phage TherapyProduct
Table 138. Innophage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 139. Innophage Recent Development
Table 140. Adaptive Phage Therapeutics Company Detail
Table 141. Adaptive Phage Therapeutics Business Overview
Table 142. Adaptive Phage Therapeutics Phage TherapyProduct
Table 143. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 144. Adaptive Phage Therapeutics Recent Development
Table 145. TechnoPhage Company Detail
Table 146. TechnoPhage Business Overview
Table 147. TechnoPhage Phage TherapyProduct
Table 148. TechnoPhage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 149. TechnoPhage Recent Development
Table 150. NPO Microgen Company Information
Table 151. NPO Microgen Business Overview
Table 152. NPO Microgen Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 153. NPO Microgen Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 154. NPO Microgen Recent Development
Table 155. Proteon Pharmaceuticals Company Information
Table 156. Proteon Pharmaceuticals Business Overview
Table 157. Proteon Pharmaceuticals Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 158. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 159. Proteon Pharmaceuticals Recent Development
Table 160. Phagelux Company Information
Table 161. Phagelux Business Overview
Table 162. Phagelux Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 163. Phagelux Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 164. Phagelux Recent Development
Table 165. Intralytix Company Information
Table 166. Intralytix Business Overview
Table 167. Intralytix Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 168. Intralytix Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 169. Intralytix Recent Development
Table 170. Micreos Company Information
Table 171. Micreos Business Overview
Table 172. Micreos Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 173. Micreos Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 174. Micreos Recent Development
Table 175. Eliava BioPreparations Company Information
Table 176. Eliava BioPreparations Business Overview
Table 177. Eliava BioPreparations Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 178. Eliava BioPreparations Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 179. Eliava BioPreparations Recent Development
Table 180. Locus Biosciences,Inc Company Information
Table 181. Locus Biosciences,Inc Business Overview
Table 182. Locus Biosciences,Inc Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 183. Locus Biosciences,Inc Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 184. Locus Biosciences,Inc Recent Development
Table 185. Pharmex Group,LLC Company Information
Table 186. Pharmex Group,LLC Business Overview
Table 187. Pharmex Group,LLC Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 188. Pharmex Group,LLC Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 189. Pharmex Group,LLC Recent Development
Table 190. Pherecydes Pharma Company Information
Table 191. Pherecydes Pharma Business Overview
Table 192. Pherecydes Pharma Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 193. Pherecydes Pharma Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 194. Pherecydes Pharma Recent Development
Table 195. APS Biocontrol Ltd. (APS) Company Information
Table 196. APS Biocontrol Ltd. (APS) Business Overview
Table 197. APS Biocontrol Ltd. (APS) Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 198. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 199. APS Biocontrol Ltd. (APS) Recent Development
Table 200. Qingdao Phagepharm Bio-tech Company Information
Table 201. Qingdao Phagepharm Bio-tech Business Overview
Table 202. Qingdao Phagepharm Bio-tech Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 203. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 204. Qingdao Phagepharm Bio-tech Recent Development
Table 205. Fixed-Phage Limited Company Information
Table 206. Fixed-Phage Limited Business Overview
Table 207. Fixed-Phage Limited Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 208. Fixed-Phage Limited Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 209. Fixed-Phage Limited Recent Development
Table 210. Zeptometrix Company Information
Table 211. Zeptometrix Business Overview
Table 212. Zeptometrix Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 213. Zeptometrix Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 214. Zeptometrix Recent Development
Table 215. Phage International, Inc. Company Information
Table 216. Phage International, Inc. Business Overview
Table 217. Phage International, Inc. Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 218. Phage International, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 219. Phage International, Inc. Recent Development
Table 220. MicroMir Company Information
Table 221. MicroMir Business Overview
Table 222. MicroMir Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 223. MicroMir Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 224. MicroMir Recent Development
Table 225. iNtODEWORLD, Inc. Company Information
Table 226. iNtODEWORLD, Inc. Business Overview
Table 227. iNtODEWORLD, Inc. Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 228. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 229. iNtODEWORLD, Inc. Recent Development
Table 230. NEXTBIOTICS Company Information
Table 231. NEXTBIOTICS Business Overview
Table 232. NEXTBIOTICS Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 233. NEXTBIOTICS Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 234. NEXTBIOTICS Recent Development
Table 235. Armata Pharmaceuticals, Inc. Company Information
Table 236. Armata Pharmaceuticals, Inc. Business Overview
Table 237. Armata Pharmaceuticals, Inc. Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 238. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 239. Armata Pharmaceuticals, Inc. Recent Development
Table 240. Innophage Company Information
Table 241. Innophage Business Overview
Table 242. Innophage Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 243. Innophage Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 244. Innophage Recent Development
Table 245. Adaptive Phage Therapeutics Company Information
Table 246. Adaptive Phage Therapeutics Business Overview
Table 247. Adaptive Phage Therapeutics Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 248. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 249. Adaptive Phage Therapeutics Recent Development
Table 250. TechnoPhage Company Information
Table 251. TechnoPhage Business Overview
Table 252. TechnoPhage Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 253. TechnoPhage Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 254. TechnoPhage Recent Development
Table 255. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Phage Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Phage Therapy Revenue Market Share by Type (2018-2023)
Table 7. Global Phage Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Phage Therapy Revenue Market Share by Type (2024-2029)
Table 9. Global Phage Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Phage Therapy Revenue Market Share by Application (2018-2023)
Table 11. Global Phage Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Phage Therapy Revenue Market Share by Application (2024-2029)
Table 13. Global Phage Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Phage Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Phage Therapy Market Share by Region (2018-2023)
Table 16. Global Phage Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Phage Therapy Market Share by Region (2024-2029)
Table 18. Phage Therapy Market Trends
Table 19. Phage Therapy Market Drivers
Table 20. Phage Therapy Market Challenges
Table 21. Phage Therapy Market Restraints
Table 22. Global Top Phage Therapy Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Phage Therapy Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Phage Therapy Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Phage Therapy, Headquarters and Area Served
Table 26. Global Phage Therapy Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Phage Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Phage Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Phage Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. NPO Microgen Company Detail
Table 46. NPO Microgen Business Overview
Table 47. NPO Microgen Phage Therapy Product
Table 48. NPO Microgen Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 49. NPO Microgen Recent Development
Table 50. Proteon Pharmaceuticals Company Detail
Table 51. Proteon Pharmaceuticals Business Overview
Table 52. Proteon Pharmaceuticals Phage Therapy Product
Table 53. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 54. Proteon Pharmaceuticals Recent Development
Table 55. Phagelux Company Detail
Table 56. Phagelux Business Overview
Table 57. Phagelux Phage Therapy Product
Table 58. Phagelux Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 59. Phagelux Recent Development
Table 60. Intralytix Company Detail
Table 61. Intralytix Business Overview
Table 62. Intralytix Phage Therapy Product
Table 63. Intralytix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 64. Intralytix Recent Development
Table 65. Micreos Company Detail
Table 66. Micreos Business Overview
Table 67. Micreos Phage Therapy Product
Table 68. Micreos Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 69. Micreos Recent Development
Table 70. Eliava BioPreparations Company Detail
Table 71. Eliava BioPreparations Business Overview
Table 72. Eliava BioPreparations Phage Therapy Product
Table 73. Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 74. Eliava BioPreparations Recent Development
Table 75. Locus Biosciences,Inc Company Detail
Table 76. Locus Biosciences,Inc Business Overview
Table 77. Locus Biosciences,Inc Phage Therapy Product
Table 78. Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 79. Locus Biosciences,Inc Recent Development
Table 80. Pharmex Group,LLC Company Detail
Table 81. Pharmex Group,LLC Business Overview
Table 82. Pharmex Group,LLC Phage Therapy Product
Table 83. Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 84. Pharmex Group,LLC Recent Development
Table 85. Pherecydes Pharma Company Detail
Table 86. Pherecydes Pharma Business Overview
Table 87. Pherecydes Pharma Phage Therapy Product
Table 88. Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 89. Pherecydes Pharma Recent Development
Table 90. APS Biocontrol Ltd. (APS) Company Detail
Table 91. APS Biocontrol Ltd. (APS) Business Overview
Table 92. APS Biocontrol Ltd. (APS) Phage Therapy Product
Table 93. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 94. APS Biocontrol Ltd. (APS) Recent Development
Table 95. Qingdao Phagepharm Bio-tech Company Detail
Table 96. Qingdao Phagepharm Bio-tech Business Overview
Table 97. Qingdao Phagepharm Bio-tech Phage TherapyProduct
Table 98. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 99. Qingdao Phagepharm Bio-tech Recent Development
Table 100. Fixed-Phage Limited Company Detail
Table 101. Fixed-Phage Limited Business Overview
Table 102. Fixed-Phage Limited Phage TherapyProduct
Table 103. Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 104. Fixed-Phage Limited Recent Development
Table 105. Zeptometrix Company Detail
Table 106. Zeptometrix Business Overview
Table 107. Zeptometrix Phage TherapyProduct
Table 108. Zeptometrix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 109. Zeptometrix Recent Development
Table 110. Phage International, Inc. Company Detail
Table 111. Phage International, Inc. Business Overview
Table 112. Phage International, Inc. Phage TherapyProduct
Table 113. Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 114. Phage International, Inc. Recent Development
Table 115. MicroMir Company Detail
Table 116. MicroMir Business Overview
Table 117. MicroMir Phage TherapyProduct
Table 118. MicroMir Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 119. MicroMir Recent Development
Table 120. iNtODEWORLD, Inc. Company Detail
Table 121. iNtODEWORLD, Inc. Business Overview
Table 122. iNtODEWORLD, Inc. Phage TherapyProduct
Table 123. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 124. iNtODEWORLD, Inc. Recent Development
Table 125. NEXTBIOTICS Company Detail
Table 126. NEXTBIOTICS Business Overview
Table 127. NEXTBIOTICS Phage TherapyProduct
Table 128. NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 129. NEXTBIOTICS Recent Development
Table 130. Armata Pharmaceuticals, Inc. Company Detail
Table 131. Armata Pharmaceuticals, Inc. Business Overview
Table 132. Armata Pharmaceuticals, Inc. Phage TherapyProduct
Table 133. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 134. Armata Pharmaceuticals, Inc. Recent Development
Table 135. Innophage Company Detail
Table 136. Innophage Business Overview
Table 137. Innophage Phage TherapyProduct
Table 138. Innophage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 139. Innophage Recent Development
Table 140. Adaptive Phage Therapeutics Company Detail
Table 141. Adaptive Phage Therapeutics Business Overview
Table 142. Adaptive Phage Therapeutics Phage TherapyProduct
Table 143. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 144. Adaptive Phage Therapeutics Recent Development
Table 145. TechnoPhage Company Detail
Table 146. TechnoPhage Business Overview
Table 147. TechnoPhage Phage TherapyProduct
Table 148. TechnoPhage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
Table 149. TechnoPhage Recent Development
Table 150. NPO Microgen Company Information
Table 151. NPO Microgen Business Overview
Table 152. NPO Microgen Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 153. NPO Microgen Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 154. NPO Microgen Recent Development
Table 155. Proteon Pharmaceuticals Company Information
Table 156. Proteon Pharmaceuticals Business Overview
Table 157. Proteon Pharmaceuticals Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 158. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 159. Proteon Pharmaceuticals Recent Development
Table 160. Phagelux Company Information
Table 161. Phagelux Business Overview
Table 162. Phagelux Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 163. Phagelux Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 164. Phagelux Recent Development
Table 165. Intralytix Company Information
Table 166. Intralytix Business Overview
Table 167. Intralytix Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 168. Intralytix Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 169. Intralytix Recent Development
Table 170. Micreos Company Information
Table 171. Micreos Business Overview
Table 172. Micreos Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 173. Micreos Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 174. Micreos Recent Development
Table 175. Eliava BioPreparations Company Information
Table 176. Eliava BioPreparations Business Overview
Table 177. Eliava BioPreparations Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 178. Eliava BioPreparations Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 179. Eliava BioPreparations Recent Development
Table 180. Locus Biosciences,Inc Company Information
Table 181. Locus Biosciences,Inc Business Overview
Table 182. Locus Biosciences,Inc Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 183. Locus Biosciences,Inc Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 184. Locus Biosciences,Inc Recent Development
Table 185. Pharmex Group,LLC Company Information
Table 186. Pharmex Group,LLC Business Overview
Table 187. Pharmex Group,LLC Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 188. Pharmex Group,LLC Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 189. Pharmex Group,LLC Recent Development
Table 190. Pherecydes Pharma Company Information
Table 191. Pherecydes Pharma Business Overview
Table 192. Pherecydes Pharma Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 193. Pherecydes Pharma Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 194. Pherecydes Pharma Recent Development
Table 195. APS Biocontrol Ltd. (APS) Company Information
Table 196. APS Biocontrol Ltd. (APS) Business Overview
Table 197. APS Biocontrol Ltd. (APS) Phage Therapy Revenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 198. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 199. APS Biocontrol Ltd. (APS) Recent Development
Table 200. Qingdao Phagepharm Bio-tech Company Information
Table 201. Qingdao Phagepharm Bio-tech Business Overview
Table 202. Qingdao Phagepharm Bio-tech Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 203. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 204. Qingdao Phagepharm Bio-tech Recent Development
Table 205. Fixed-Phage Limited Company Information
Table 206. Fixed-Phage Limited Business Overview
Table 207. Fixed-Phage Limited Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 208. Fixed-Phage Limited Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 209. Fixed-Phage Limited Recent Development
Table 210. Zeptometrix Company Information
Table 211. Zeptometrix Business Overview
Table 212. Zeptometrix Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 213. Zeptometrix Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 214. Zeptometrix Recent Development
Table 215. Phage International, Inc. Company Information
Table 216. Phage International, Inc. Business Overview
Table 217. Phage International, Inc. Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 218. Phage International, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 219. Phage International, Inc. Recent Development
Table 220. MicroMir Company Information
Table 221. MicroMir Business Overview
Table 222. MicroMir Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 223. MicroMir Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 224. MicroMir Recent Development
Table 225. iNtODEWORLD, Inc. Company Information
Table 226. iNtODEWORLD, Inc. Business Overview
Table 227. iNtODEWORLD, Inc. Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 228. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 229. iNtODEWORLD, Inc. Recent Development
Table 230. NEXTBIOTICS Company Information
Table 231. NEXTBIOTICS Business Overview
Table 232. NEXTBIOTICS Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 233. NEXTBIOTICS Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 234. NEXTBIOTICS Recent Development
Table 235. Armata Pharmaceuticals, Inc. Company Information
Table 236. Armata Pharmaceuticals, Inc. Business Overview
Table 237. Armata Pharmaceuticals, Inc. Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 238. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 239. Armata Pharmaceuticals, Inc. Recent Development
Table 240. Innophage Company Information
Table 241. Innophage Business Overview
Table 242. Innophage Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 243. Innophage Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 244. Innophage Recent Development
Table 245. Adaptive Phage Therapeutics Company Information
Table 246. Adaptive Phage Therapeutics Business Overview
Table 247. Adaptive Phage Therapeutics Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 248. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 249. Adaptive Phage Therapeutics Recent Development
Table 250. TechnoPhage Company Information
Table 251. TechnoPhage Business Overview
Table 252. TechnoPhage Phage TherapyRevenue in Phage Therapy Business (2018-2023) & (US$ Million)
Table 253. TechnoPhage Revenue in Phage Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 254. TechnoPhage Recent Development
Table 255. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Phage Therapy Product Picture
Figure 5. Global Phage Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Phage Therapy Market Share by Type: 2022 VS 2029
Figure 7. DsDNA Bacteriophage Product Picture
Figure 8. SsDNA Bacteriophage Product Picture
Figure 9. SsRNA Bacteriophage Product Picture
Figure 10. Others Product Picture
Figure 11. Global Phage Therapy Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Phage Therapy Market Share by Application: 2022 VS 2029
Figure 13. Animal Health Product Picture
Figure 14. Aquaculture Product Picture
Figure 15. Agriculture Product Picture
Figure 16. Food Industry Product Picture
Figure 17. Human Health Product Picture
Figure 18. Others Product Picture
Figure 19. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Phage Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Phage Therapy Market Share by Region: 2022 VS 2029
Figure 22. Global Phage Therapy Market Share by Players in 2022
Figure 23. Global Phage Therapy Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Phage Therapy Market Share by Country (2018-2029)
Figure 28. United States Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Phage Therapy Market Share by Country (2018-2029)
Figure 32. Germany Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Phage Therapy Market Share by Country (2018-2029)
Figure 40. China Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Phage Therapy Market Share by Country (2018-2029)
Figure 48. Mexico Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Phage Therapy Market Share by Country (2018-2029)
Figure 52. Turkey Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 56. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 57. Phagelux Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 58. Intralytix Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 59. Micreos Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 60. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 61. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 62. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 63. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 64. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 65. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 66. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 67. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 68. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 69. MicroMir Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 70. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 71. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 72. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 73. Innophage Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 74. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 75. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Phage Therapy Product Picture
Figure 5. Global Phage Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Phage Therapy Market Share by Type: 2022 VS 2029
Figure 7. DsDNA Bacteriophage Product Picture
Figure 8. SsDNA Bacteriophage Product Picture
Figure 9. SsRNA Bacteriophage Product Picture
Figure 10. Others Product Picture
Figure 11. Global Phage Therapy Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Phage Therapy Market Share by Application: 2022 VS 2029
Figure 13. Animal Health Product Picture
Figure 14. Aquaculture Product Picture
Figure 15. Agriculture Product Picture
Figure 16. Food Industry Product Picture
Figure 17. Human Health Product Picture
Figure 18. Others Product Picture
Figure 19. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Phage Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Phage Therapy Market Share by Region: 2022 VS 2029
Figure 22. Global Phage Therapy Market Share by Players in 2022
Figure 23. Global Phage Therapy Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Phage Therapy Market Share by Country (2018-2029)
Figure 28. United States Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Phage Therapy Market Share by Country (2018-2029)
Figure 32. Germany Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Phage Therapy Market Share by Country (2018-2029)
Figure 40. China Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Phage Therapy Market Share by Country (2018-2029)
Figure 48. Mexico Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Phage Therapy Market Share by Country (2018-2029)
Figure 52. Turkey Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Phage Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 56. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 57. Phagelux Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 58. Intralytix Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 59. Micreos Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 60. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 61. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 62. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 63. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 64. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 65. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 66. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 67. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 68. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 69. MicroMir Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 70. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 71. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 72. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 73. Innophage Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 74. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2018-2023)
Figure 75. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2018-2023)
